Monoclonal Antibody for COVID Gets FDA Emergency Use Authorization

The FDA on Tuesday granted emergency use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients.
Reuters Health Information

source https://www.medscape.com/viewarticle/990441?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost